The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Background The investigational 9-valent viruslike particle vaccine against human
papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6 …

Background The rate of anal cancer is increasing among both women and men, particularly
men who have sex with men. Caused by infection with human papillomavirus (HPV) …

Background The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …

Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …

Human papillomaviruses (HPVs) are ubiquitous, well adapted to their host and cleverly
sequestered away from immune responses. HPV infections can be productive, subclinical or …

Genital HPV infection is associated with development of cervical cancer, cervical neoplasia,
anogenital warts, and other anogenital cancers. A number of reviews have primarily …

Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …

Background The long-term effectiveness of the quadrivalent human papillomavirus (qHPV)
vaccine was assessed by monitoring the combined incidence of cervical intraepithelial …